HLB Genex has been growing earnings at an average annual rate of 37.3%, while the Chemicals industry saw earnings declining at 0.3% annually. Revenues have been growing at an average rate of 14.7% per year. HLB Genex's return on equity is 40.6%, and it has net margins of 48.3%.
How HLB Genex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A187420 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
44,346
21,414
7,643
5,980
31 Dec 25
43,370
22,591
7,218
5,903
30 Sep 25
40,950
-3,267
6,490
7,936
30 Jun 25
39,914
-88
6,063
8,289
31 Mar 25
39,009
-18,567
5,643
9,665
31 Dec 24
35,430
-18,828
5,343
10,271
30 Sep 24
34,834
1,045
2,370
8,929
30 Jun 24
32,197
-2,856
3,911
11,021
31 Mar 24
28,048
-1,444
3,841
10,997
31 Dec 23
27,008
-2,950
4,025
11,608
30 Sep 23
25,340
-15,879
5,882
13,050
30 Jun 23
25,467
-13,668
4,356
11,891
31 Mar 23
27,827
-13,706
4,476
12,147
31 Dec 22
27,802
-12,968
4,230
11,681
30 Sep 22
27,274
-8,837
4,183
11,541
30 Jun 22
27,140
-8,641
3,716
11,457
31 Mar 22
26,427
-8,222
3,360
11,570
31 Dec 21
25,874
-6,817
2,913
10,413
30 Sep 21
22,921
-10,312
2,828
10,370
30 Jun 21
20,533
-10,298
2,567
9,810
31 Mar 21
19,258
-13,035
2,451
8,274
31 Dec 20
18,769
-12,217
2,364
8,025
30 Sep 20
18,853
-5,142
2,290
5,922
30 Jun 20
17,807
-5,729
2,181
5,149
31 Mar 20
16,287
-5,907
2,189
4,983
31 Dec 19
14,942
-5,759
2,151
4,261
30 Sep 19
12,878
-5,952
1,975
3,401
30 Jun 19
13,169
-3,427
1,928
2,144
31 Mar 19
12,388
-3,020
1,767
1,202
31 Dec 18
11,518
-2,323
1,808
899
30 Sep 18
11,592
-43
1,649
671
30 Jun 18
11,138
433
1,645
537
31 Mar 18
11,685
1,457
1,772
359
31 Dec 17
11,506
1,411
1,594
352
30 Sep 17
10,922
2,044
1,589
295
30 Jun 17
9,895
2,214
1,532
360
31 Mar 17
8,054
2,123
1,302
331
31 Dec 16
7,029
1,615
1,265
265
30 Sep 16
6,562
874
1,188
247
30 Jun 16
6,461
1,243
1,146
124
31 Mar 16
6,654
1,187
1,071
108
31 Dec 15
6,640
1,211
978
136
30 Sep 15
8,410
3,192
910
203
30 Jun 15
7,796
2,569
858
208
Quality Earnings: A187420 has a high level of non-cash earnings.
Growing Profit Margin: A187420 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A187420 has become profitable over the past 5 years, growing earnings by 37.3% per year.
Accelerating Growth: A187420 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A187420 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.5%).
Return on Equity
High ROE: A187420's Return on Equity (40.6%) is considered outstanding.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/24 23:57
End of Day Share Price
2026/06/24 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HLB Genex, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.